Abbvie Biotherapeutics Inc.

Intersil Americas Inc.

Ping Y Huang

J Yun Tso

Taymar E Hartman

Paul W Sauer

John E Burky

Mark C Wesson

Thomas J Robinson

Braeden D Partridge

David Powers

Patricia Culp

Hoa Vu

Yoshiko Akamatsu

Shiming Ye

Charles M Forsyth

Alan F Wahl

The present disclosure provides bispecific proteins that bind to two antigens, as well as their compositions, uses, and methods of making.

Bispecific binding proteins that bind CD40 and mesothelin

The present disclosure relates to compositions of daclizumab suitable for subcutaneous administration and methods of manufacturing thereof.

DAC HYP compositions

DAC HYP compositions and methods

A method for controlling performance of an integrated circuit using a zero-pin serial interface is provided. The method comprises identifying a desired performance characteristic of the circuit, and transmitting a first change mode signal to the circuit on a first pin to cause the circuit to enter an instruction reception mode, with the first pin performing differently during a normal operation mode. The method also comprises transmitting a performance adjusting instruction to the circuit on a second pin when the circuit is in the instruction reception mode, with the second pin performing differently during the normal operation mode, and transmitting a second change mode signal to the circuit on the first pin to cause the circuit to enter the normal operation mode. An output performance of the circuit is compared to the desired performance characteristic, with the output performance being the performance of the circuit during the normal operation mode. The circuit is set to permanently provide the output performance when the output performance is within a desired tolerance of the desired performance characteristic.

Zero pin serial interface

Growing community of inventors

Fremont, CA, United States of America

Ping Y Huang